DS
FOLD

DRW Securities’s Amicus Therapeutics FOLD Stock Holding History

DRW Securities’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
70,670
+49,670
+237% +$712K 0.01% 330
2025
Q4 		$299K Sell
21,000
-20,027
-49% -$197K 0.01% 679
2025
Q3 		$318K Sell
41,027
-52,360
-56% -$373K 0.01% 812
2025
Q2 		$535K Buy
+93,387
New +$603K 0.01% 470
2014
Q1 		– Sell
-33,593
Closed -$79K – 161
2013
Q4 		$79K Buy
+33,593
New +$73.7K ﹤0.01% 212

Other funds holding FOLD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

DRW Securities's FOLD Position: Q1 2026 in Review

DRW Securities increased its Amicus Therapeutics (FOLD) stake by 237% in Q1 2026, buying an estimated $712K and bringing the position to 70,670 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #330.

DRW Securities first reported a position in FOLD in Q4 2013 and has held it in 5 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • DRW Securities held 70,670 shares of Amicus Therapeutics worth $1.02M as of Q1 2026.
  • DRW Securities bought 49,670 Amicus Therapeutics shares in Q1 2026, an estimated $712K.
  • Amicus Therapeutics made up 0.01% of DRW Securities's portfolio in Q1 2026, its #330 holding.
  • DRW Securities first reported a position in Amicus Therapeutics in Q4 2013 and has held it in 5 quarters since.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.